Rehaler (private company)
See something wrong or missing? Let us know
Offices:Copenhagen
Industry:Health servicesManufacturing
Business model:B2B
Rehaler (former BalancAir) is a biomedical company developing and commercializing novel treatments based on modulation of CO2 and oxygen in the central nervous system. The company's product is a consumer device for treating acute migraine attacks.
Rehaler was folded in 2024.
Investors:
we tracked 2 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 2.52M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Rehaler
Name | Criteria | |
---|---|---|
![]() |
2Eyes Vision
52%
|
|
![]() |
AorticLab
52%
|
|
![]() |
Berries by Astrid
52%
|
|
![]() |
Devicare
52%
|
|
![]() |
FinnAdvance
52%
|
|
![]() |
Nukute
52%
|
|
![]() |
Octarine Bio
52%
|
|
![]() |
Oivi
52%
|
|
![]() |
Pharmedigroup
52%
|
|
![]() |
Pilloxa
52%
|
|